Results of patch testing 2‐hydroxyethyl methacrylate ( HEMA ) in the European baseline series: A 4‐year retrospective study
Contact Dermatitis · 2024
DOI: 10.1111/cod.14488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contact Dermatitis, 2024. Verfasst von Gizem Kocabas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam University Medical Centers, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact, Cosmetics, Dermatitis, Occupational. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
2‐Hydroxyethyl methacrylate (HEMA) was added to the European baseline series (EBS) in 2019. Few recent data are available on the frequency and relevance of positive reactions to this hapten.
Objectives
To investigate the frequency and relevance of positive patch tests to HEMA in the EBS in a university hospital in Amsterdam, The Netherlands. Patients and Methods Retrospective study in patients with positive patch tests to HEMA investigated between June 2019 and August 2023.
Results
Of 2927 consecutive patients, 88 (79 women and 9 men; 3.0%) had a positive reaction to HEMA. The prevalence in women was 3.9%, in men 1.0%. Forty‐three (49%) reactions were judged to be of current clinical relevance and 21 (24%) of past relevance. In this group of 64 patients with relevant reactions, 18 (28%) had occupational contact with (meth)acrylate‐containing products, of who 11 (61%) were nail stylists. In 46 patients with non‐occupational allergic contact dermatitis, 31 (67%) had allergic reactions to nail cosmetics. Glues and glue‐containing products accounted for 22% of the materials causing allergic contact dermatitis and dental products for 8%.
Conclusions
Allergic reactions to HEMA are very frequent in women investigated in Amsterdam. Nearly two thirds of cases were caused by nail cosmetics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amsterdam University Medical Centers, Amsterdam, The Netherlands.
- Dermato-Allergology and Occupational Dermatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
ORCID-Profile: Anton de Groot, Thomas Rustemeyer
Zitieren
APA
Kocabas, G., Steunebrink, I. M., de Groot, A., & Rustemeyer, T. (2024). Results of patch testing 2‐hydroxyethyl methacrylate ( HEMA ) in the European baseline series: A 4‐year retrospective study. Contact Dermatitis. https://doi.org/10.1111/cod.14488
Vancouver
Kocabas G, Steunebrink IM, de Groot A, Rustemeyer T. Results of patch testing 2‐hydroxyethyl methacrylate ( HEMA ) in the European baseline series: A 4‐year retrospective study. Contact Dermatitis. 2024. doi:10.1111/cod.14488
BibTeX
@article{Kocabas2024,
author = {Kocabas, Gizem and Steunebrink, Iemke M and de Groot, Anton and Rustemeyer, Thomas},
title = {Results of patch testing 2‐hydroxyethyl methacrylate ( HEMA ) in the European baseline series: A 4‐year retrospective study},
journal = {Contact Dermatitis},
year = {2024},
doi = {10.1111/cod.14488}
}
EUVIMED